Business Description
Keymed Biosciences Inc
ISIN : KYG5252B1023
Compare
Compare
Traded in other countries / regions
02162.Hong Kong64Z.Germany IPO Date
2022-05-13Description
Keymed Biosciences Inc is a biotechnology company with multiple clinical-stage assets. The company is focused on the in-house discovery and development of biological therapies that address large underserved medical needs in the autoimmune and oncology therapeutic areas. Its clinical-stage drug candidates include CM310, CM326, CM313, and CM336 among others. The company is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment. Geographically, it generates a majority of its revenue from overseas markets and the rest from Mainland China.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.49 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.14 | |||||
| Debt-to-EBITDA | -1.55 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 5.43 | |||||
| Beneish M-Score | 0.51 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 31 | |||||
| 3-Year EPS without NRI Growth Rate | 25.2 | |||||
| 3-Year FCF Growth Rate | -67.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 71.14 | |||||
| 9-Day RSI | 70.24 | |||||
| 14-Day RSI | 65.92 | |||||
| 6-1 Month Momentum % | -37.74 | |||||
| 12-1 Month Momentum % | -43.24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.36 | |||||
| Quick Ratio | 9.18 | |||||
| Cash Ratio | 8.65 | |||||
| Days Inventory | 601.16 | |||||
| Days Sales Outstanding | 11.19 | |||||
| Days Payable | 259.91 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.7 | |||||
| Shareholder Yield % | -1.95 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 89.59 | |||||
| Operating Margin % | -122.79 | |||||
| Net Margin % | -101.49 | |||||
| FCF Margin % | -193.42 | |||||
| ROE % | -11.03 | |||||
| ROA % | -9.01 | |||||
| ROIC % | -43.45 | |||||
| ROC (Joel Greenblatt) % | -42.21 | |||||
| ROCE % | -9.21 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 27.69 | |||||
| PB Ratio | 3.43 | |||||
| Price-to-Tangible-Book | 3.36 | |||||
| EV-to-EBIT | -22.67 | |||||
| EV-to-EBITDA | -28.48 | |||||
| EV-to-Revenue | 21.71 | |||||
| EV-to-FCF | -11.59 | |||||
| Price-to-Net-Current-Asset-Value | 4.94 | |||||
| Price-to-Net-Cash | 5.52 | |||||
| Earnings Yield (Greenblatt) % | -4.41 | |||||
| FCF Yield % | -6.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Keymed Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 45.626 | ||
| EPS (TTM) (€) | -0.176 | ||
| Beta | 0 | ||
| Volatility % | 65.41 | ||
| 14-Day RSI | 65.92 | ||
| 14-Day ATR (€) | 0.131018 | ||
| 20-Day SMA (€) | 4.013 | ||
| 12-1 Month Momentum % | -43.24 | ||
| 52-Week Range (€) | 3.24 - 7 | ||
| Shares Outstanding (Mil) | 276.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Keymed Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Keymed Biosciences Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Keymed Biosciences Inc Frequently Asked Questions
What is Keymed Biosciences Inc(FRA:64Z)'s stock price today?
The current price of FRA:64Z is €4.64. The 52 week high of FRA:64Z is €7.00 and 52 week low is €3.24.
When is next earnings date of Keymed Biosciences Inc(FRA:64Z)?
The next earnings date of Keymed Biosciences Inc(FRA:64Z) is .
Does Keymed Biosciences Inc(FRA:64Z) pay dividends? If so, how much?
Keymed Biosciences Inc(FRA:64Z) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers